{
  "id": 10339506,
  "title": "Heartflow CFO Vikram Verghese sells $1.23m in company stock",
  "url": "https://urgent.news/2026/09/28/heartflow-cfo-vikram-verghese-sells-1-23m-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T02:01:20.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/heartflow-cfo-vikram-verghese-sells-123m-in-company-stock-93CH-4919258"
  },
  "original_language": "en",
  "account": "Vikram Verghese, CFO of Heartflow Inc., divested $1.23 million worth of the company's stock in two transactions on September 17 and 18, 2026. The sales were made under a pre-arranged Rule 10b5-1 trading plan, adopted on June 4, 2026. The stock was trading near its 52-week high of $52.22 at the time of sale, currently priced at $49.17. According to InvestingPro Tips, Heartflow delivered strong returns over the past three months and significant gains over the last six months, with a 99% increase over six months. However, the stock is currently considered overvalued according to InvestingPro analysis. Verghese sold 7,579 shares on September 17, at prices ranging from $50.00 to $50.29 per share, followed by an additional 16,766 shares on September 18, sold at prices between $50.00 and $52.11 per share. After these transactions, he directly owns 155,183 shares of Heartflow common stock. Heartflow reported a narrower-than-expected loss for Q2 2026, with adjusted earnings of -$0.07 per share, beating expectations of -$0.19. Revenue for the quarter rose by 48% to $64.1 million, driven by increased demand for its coronary artery disease diagnostics. This revenue surpassed both Stifel's projection ($56.7 million) and consensus estimates ($56.6 million). As a result, Stifel raised its price target for HeartFlow shares to $45, maintaining a Buy rating. Canaccord also raised its price target to $56, while maintaining a Buy rating, based on an expanded plaque analysis survey. These developments indicate growing interest and a positive outlook from analysts regarding HeartFlow's performance and potential.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Viant technology CFO Larry Madden sells $390k in stock",
        "url": "https://urgent.news/2026/09/28/viant-technology-cfo-larry-madden-sells-390k-in-stock",
        "published": "2026-09-28T02:01:14.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}